GeneDx Holdings Corp. Faces Securities Class Action Lawsuit Amid Sharp Share Price Decline

Shares of GeneDx Holdings Corp (NASDAQ: WGS) dropped by $33.42, or nearly 50%, following a significant impairment charge and revised revenue guidance. Institutional investors are being alerted to potential fiduciary obligations due to the decline.

By Levi & Korsinsky, LLP · PR Newswire ·

GeneDx Holdings Corp. Faces Securities Class Action Lawsuit Amid Sharp Share Price Decline

Tickers: $WGS

Topics: class action fiduciary obligations investor losses stock price decline

Read the full article at PR Newswire

More Politics news